TFSA Investors: Should You Buy the Dip in Ark Innovation ETF?

Investors with a high risk profile and a long-term horizon could consider buying the dip in ARKK ETF.

| More on:
ETF chart stocks

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The TFSA (Tax-Free Savings Account) is a registered account where investors can generate tax-free gains. Here, returns in the form of dividends, interests, or capital gains are exempt from Canada Revenue Agency taxes, making the TFSA an ideal account to hold growth stocks over the long term.

The ongoing sell-off provides investors a massive opportunity to buy quality companies at a lower multiple. Alternatively, you can also look to invest in growth ETFs (exchange-traded funds) especially if you don’t have the expertise or time to pick individual stocks. ETF investing provides a cost-efficient way to gain exposure to the equity market while diversifying overall risk.

Cathie Wood is among the most well-known names on Wall Street. An institutional investor, Wood’s Ark Innovation ETF (NYSE:ARKK) gained popularity in 2020 after the ETF returned over 150% to investors that year. However, the ARKK ETF is since down 54% from all-time highs. Despite the pullback, ARKK is up 258% in the last five years, significantly higher than the S&P 500 returns of 112% in this period.

Let’s see if the ARKK ETF should be part of your TFSA portfolio right now.

An overview of the ARKK ETF

An actively managed ETF, ARKK, aims to allocate a significant portion of its investments toward disruptive innovation companies. ARKK defines disruptive innovation as the introduction of a product or service that can potentially change the way the world operates.

These companies are primarily part of verticals that include fintech innovation, automation, robotics & energy storage, artificial intelligence, and DNA technologies among others. With more than US$16 billion in assets under management, the ARKK ETF has a management fee of 0.75%.

The four largest sectors represented in ARKK ETF are cloud computing, online commerce, digital media, and gene therapy. Investors will also get exposure to verticals such as the internet of things, alternative energy, and robotics, among others. Its top three holdings include growth stocks such as Tesla, Roku, and Teladoc Health.

Why investing in ARKK ETF is high risk

In an interview with CNBC last November, Cathie Wood disclosed that ARK Invest might start shorting stocks as an investment strategy. Wood said the new strategy is referred to as “ARK on steroids”. Experts believe shorting stocks is a high-risk game and Wood might be motivated by the underperformance of the company’s returns in the last year.

However, the strategy will first be tested out before it is implemented. Wood also emphasized that ARK Invest is continuing to implement a long-term approach while investing in the equity market.

The ARKK ETF provides investors with an aggressive growth option and is ideal for those with a high risk profile. Its focus on growth stocks suggests that the ETF’s beta score will be inherently high. For example, growth stocks significantly underperform the market when sentiments turn bearish. However, they also can crush the broader indexes in a bull run.

One of the ARKK ETF’s holdings, Roku, gained close to 2,000% between its IPO in late 2017 and February 2021. Right now, it’s down 68% from record highs but has still returned 547% to investors in less than five years.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool recommends Roku, Teladoc Health, and Tesla.

More on Tech Stocks

A worker uses a double monitor computer screen in an office.
Tech Stocks

Why Shopify Stock Sold Off Last Week

Shopify (TSX:SHOP) sold off heavily last week. A bad earnings release may have been the culprit.

Read more »

Hand arranging wood block stacking as step stair with arrow up.
Tech Stocks

2 Phenomenal Growth Stocks Down 30-60% That Could Rally in the Next Bull Market

Is it time to buy growth stocks? The worst of the interest rate hike and inflation is over, and now…

Read more »

stock market
Tech Stocks

2 Best Tech Stocks to Buy Before the Next Bull Market

Tech stocks such as Roku and Nuvei can help long-term investors generate outsized gains in 2023 and beyond.

Read more »

Wireless technology
Tech Stocks

Tucows Stock Trades Near its 6-Year Low: Is it a Buy?  

Tucows stock fell 63% in the tech stock sell-off and has failed to show any recovery. Is this domain and…

Read more »

Male IT Specialist Holds Laptop and Discusses Work with Female Server Technician. They're Standing in Data Center, Rack Server Cabinet with Cloud Server Icon and Visualization
Tech Stocks

Is Converge Stock a Buy?

A relatively new tech stock could soar higher with the pause in rate hikes, although a resumption of the cycle…

Read more »

online shopping
Tech Stocks

Up by 25%: Is Shopify Stock Finally a Buy in 2023?

The strong rebound in the TSX’s top tech stock remains uncertain. Investors will have to wait before it delivers stellar…

Read more »

Businessman holding AI cloud
Tech Stocks

2 TSX Tech Stocks Innovating Hard in AI

Shopify (TSX:SHOP) stock and another intriguing Canadian gem make good use of AI technologies.

Read more »

worry concern
Tech Stocks

Shopify Stock: Incredible Bargain or Deceptive Trap?

Shopify has quickly shifted from a market darling to something else. Is it a safe buy or risqué bet?

Read more »